Meghan Fuentes

Meghan Fuentes is a financial analyst with extensive experience in clinical, financial planning, and control functions. Currently serving as a Senior Financial Analyst - Clinical at Enanta Pharmaceuticals since March 2022, Meghan has previously held senior financial analyst roles at Epizyme and The TJX Companies, Inc. At Epizyme, responsibilities included supporting clinical, regulatory, and medical affairs with financial planning processes, while at The TJX Companies, duties involved analyzing gross margin and inventory components for senior leadership. Meghan started their career as a DAS Finance Intern at PerkinElmer, where focus areas included monthly and quarterly operating reviews and standard reporting. Additionally, Meghan contributed to the Human Rights Campaign as a field canvasser and advocate in 2017. Meghan holds a Bachelor of Science degree in Business with a concentration in Finance and Statistical Modeling from Babson College.